Skip to main content
. 2015 Dec 28;31(1):125–133. doi: 10.3904/kjim.2016.31.1.125

Table 3.

Characteristics of CDI patients according to the more advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m2)

Characteristic CDI patients with eGFR ≥ 30 (n = 139) CDI patients with eGFR < 30 (n = 32) p value
Age, yr 74 (64–79) 71 (57–74) 0.987
Male sex 64 (46.0) 22 (68.8) 0.030
History
 Diabetes 43 (30.9) 13 (40.6) 0.303
 Hypertension 74 (53.2) 29 (90.6) 0.000
 ICU admission in the past 90 days 47 (33.8) 17 (53.1) 0.067
Antibiotic use in the past 42 days
 Use of any antibiotic 128 (92.1) 29 (90.6) 0.728
 Use of two or more antibiotics 74 (53.2) 15 (46.9) 0.560
 Cephalosporin use 85 (62.1) 22 (66.8) 0.544
 Quinolone use 46 (33.1) 7 (21.9) 0.290
 Carbapenem use 23 (16.5) 2 (6.2) 0.172
 Macrolide use 6 (4.3) 3 (9.4) 0.372
 Trimethoprim/sulfamethoxazole use 7 (5.0) 1 (3.1) 1.000
 Metronidazole use 9 (6.5) 1 (3.1) 0.690
 Use of antifungal agents 10 (7.2) 0 0.211
 Tazocin use 24 (17.3) 8 (25.0) 0.321
 Vancomycin use 7 (5.0) 1 (3.1) 1.000
GARD use in the past 42 days 92 (66.2) 24 (75.0) 0.405
Fever (> 38.3°C) 47 (33.8) 8 (25.0) 0.405
Shock (SBP < 90 mmHg) 13 (9.4) 4 (12.5) 0.528
Acute kidney injury 12 (8.6) 4 (12.5) 0.505
Albumin 3.0 (2.7–3.3) 2.9 (2.6–3.0) 0.175
Hemoglobin A1c 5.9 (5.4–6.7) 6.0 (5.7–6.6) 0.924
WBC count > 15 × 103/µL 37 (26.6) 16 (50.0) 0.018
CDI treatment at diagnosis
 Metronidazole 129 (92.8) 30 (93.8) 1.000
 Vancomycin 10 (7.2) 2 (6.2) 1.000
Switched from metronidazole to vancomycin 17 (12.2) 9 (28.1) 0.031
Recurrence of CDI 17 (12.5) 4 (14.8) 0.755
In-hospital mortality 7 (5.0) 7 (21.9) 0.006
Length of hospital stay, day 39.5 (19–68) 45 (25–72) 0.891
 Time from admission to diagnosis 17(8–31) 23 (8–38) 0.632
 Time from diagnosis to discharge 15.5 (6–44) 17 (9–38) 0.921

Values are presented as median (confidence interval 25%–75%) or number of patients (%).

CDI, Clostridium difficile infection; eGFR, estimated glomerular filtration rate; ICU, intensive care unit; GARD, gastric acid-reducing drug; SBP, systolic blood pressure; WBC, white blood cell.